WebOct 1, 2024 · Comprehensive profiling and molecularly guided therapy (MGT) for carcinomas of unknown primary (CUP): CUPISCO: A phase II, randomised, multicentre study comparing targeted therapy or immunotherapy with standard platinum-based chemotherapy - Annals of Oncology Abstracts Developmental therapeutics Volume 29, SUPPLEMENT … WebCUP (cancer of unknown primary) syndrome is defined as a cancer for which only metastases but no primary tumour or site of origin are detectable at the end of a …
Warner Robins Obituaries Local Obits for Warner Robins, GA
WebMar 9, 2024 · Abstract Background CUPISCO is an ongoing randomized phase II trial (NCT03498521) ... (CUP); however, study in a trial setting is faced with the significant challenge of definitively distinguishing CUP from other cancer types. This article reports the authors' experience of this challenge so far in the ongoing CUPISCO trial, which … WebCUPISCO-Studie Unter unserer Leitung wird derzeit eine große, internationale Therapiestudie (CUPISCO) durchgeführt, mit der untersucht wird ob molekular … cook county sheriff division 8
A challenging task – Identifying carcinoma of unknown primary …
WebNov 27, 2024 · CUPISCO is a phase II, randomized, multicenter study of patients with newly diagnosed, unfavorable CUP (NCT03498521) that will compare the efficacy and safety of targeted therapy or cancer immunotherapy, guided by genomic profiling, with platinum-based standard chemotherapy [ 10 ]. WebStudie CUPISCO. V této části vám představíme studii CUPISCO. Cílem tohoto klinického hodnocení je stanovit účinnost a bezpečnost cílených terapií a imunoterapií malignit u pacientů s podskupinou CUP. Výběr terapií je založen na výsledcích komplexního genomového profilování. další informace WebNov 20, 2024 · Conclusions: Thirty-two percent of patients would have been eligible for targeted therapy in CUPISCO. Future studies, including additional biomarkers such as PD-L1 positivity and gLOH, may ... family care dillsburg